INDEMNIFICATION AGREEMENTIndemnification Agreement • August 12th, 2022 • Genprex, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of May 17, 2022 by and between Genprex, Inc., a Delaware corporation (the “Company”), and [•] (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
GENPREX, INC. WARRANT AGREEMENT July 1, 2022Warrant Agreement • August 12th, 2022 • Genprex, Inc. • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, Bear Creek Capital LLC or its successors and permitted assigns pursuant to the terms hereof (the “Warrantholder”), is entitled to purchase from Genprex, Inc., a Delaware corporation (the “Company”), subject to the terms set forth below, fifty-thousand (50,000) fully paid and non-assessable shares (subject to adjustment as provided herein) (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $1.38 in cash per Warrant Share (the “Exercise Price”), subject to the provisions and upon the terms and conditions hereinafter set forth. The term “Warrant Agreement” as used herein shall refer to this Warrant Agreement, as the same may be amended or amended and restated. This Warrant Agreement is being issued under that certain consulting agreement dated as of May 13, 2021 as extended by an extension agreement dated as of July 1, 2021 (the “First Extension”) as further extended by an e
